Hematology TimesIsrael approves ponatinib for CML, Ph+ ALLMarch 27, 2015Leukemia, Myelodysplasia, TransplantationPharmacyALLCML
Hematology TimesNICE OKs rivaroxaban, rejects pomalidomideMarch 26, 2015Multiple MyelomaThrombosisPharmacy
Hematology TimesLowering the cost of cancer drugs in the USMarch 17, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHematology NursingPharmacyRelated Issues
Hematology TimesDrug incompatible with certain devices, FDA warnsMarch 12, 2015Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesFDA approves first biosimilar productMarch 9, 2015AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPharmacyTransplantationAML
Hematology TimesToo many blood tests can lead to anemia, transfusionsMarch 3, 2015AnemiaBlood BankingPharmacy
